A detailed history of Valmark Advisers, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Valmark Advisers, Inc. holds 43,686 shares of PFE stock, worth $1.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
43,686
Previous 48,198 9.36%
Holding current value
$1.3 Million
Previous $1.34 Million 8.6%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$25.26 - $29.6 $113,973 - $133,555
-4,512 Reduced 9.36%
43,686 $1.22 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $62,627 - $71,916
2,419 Added 5.28%
48,198 $1.34 Million
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $66,553 - $86,445
-2,547 Reduced 5.27%
45,779 $1.32 Million
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $56,414 - $65,942
-1,758 Reduced 3.51%
48,326 $1.6 Million
Q2 2023

Aug 02, 2023

SELL
$36.12 - $41.79 $41,682 - $48,225
-1,154 Reduced 2.25%
50,084 $1.84 Million
Q1 2023

May 01, 2023

BUY
$39.39 - $51.28 $33,560 - $43,690
852 Added 1.69%
51,238 $2.09 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $370,239 - $483,306
8,868 Added 21.36%
50,386 $2.58 Million
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $3,194 - $3,899
-73 Reduced 0.18%
41,518 $1.82 Million
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $29,965 - $35,529
644 Added 1.57%
41,591 $2.18 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $84,088 - $104,196
-1,838 Reduced 4.3%
40,947 $2.12 Million
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $380,391 - $563,867
9,206 Added 27.42%
42,785 $2.53 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $283,463 - $364,133
-7,222 Reduced 17.7%
33,579 $1.44 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $33,216 - $37,629
925 Added 2.32%
40,801 $1.6 Million
Q1 2021

May 04, 2021

BUY
$33.49 - $37.77 $71,534 - $80,676
2,136 Added 5.66%
39,876 $1.45 Million
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $199,447 - $253,615
5,959 Added 18.75%
37,740 $1.39 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $14,954 - $17,544
-471 Reduced 1.46%
31,781 $1.17 Million
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $15,662 - $19,000
-520 Reduced 1.59%
32,252 $1.06 Million
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $12,352 - $17,649
-457 Reduced 1.38%
32,772 $1.07 Million
Q4 2019

Jan 31, 2020

SELL
$32.92 - $37.36 $43,322 - $49,165
-1,316 Reduced 3.81%
33,229 $1.3 Million
Q3 2019

Nov 06, 2019

BUY
$32.49 - $42.13 $44,836 - $58,139
1,380 Added 4.16%
34,545 $1.24 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $75,956 - $85,282
2,054 Added 6.6%
33,165 $1.44 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $1,687 - $1,854
-45 Reduced 0.14%
31,111 $1.32 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $97,867 - $111,579
2,544 Added 8.89%
31,156 $1.36 Million
Q2 2018

Aug 07, 2018

BUY
$32.98 - $35.16 $30,803 - $32,839
934 Added 3.37%
28,612 $1.04 Million
Q1 2018

May 07, 2018

SELL
$31.91 - $37.02 $13,146 - $15,252
-412 Reduced 1.47%
27,678 $982,000
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $934,273 - $991,296
28,090
28,090 $1.02 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Valmark Advisers, Inc. Portfolio

Follow Valmark Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.